Paloma Partners Management CO Biotechnology

Paloma Partners Management CO

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
REGN Regeneron Pharmaceuticals, Inc.	$72.1B	$657,000 0.02% of portfolio	625	Q3 2024 Added 11.01%
EXEL Exelixis, Inc.	$10.7B	$483,000 0.02% of portfolio	18,635	Q3 2024 New
INCY Incyte Corp	$16.5B	$462,000 0.01% of portfolio	7,000	Q3 2024 Reduced 15.66%
MRNA Moderna, Inc.	$15.4B	$318,000 0.01% of portfolio	4,768	Q3 2024 Reduced 19.96%
ROIV Roivant Sciences Ltd.	$7.84B	$312,000 0.01% of portfolio	27,040	Q3 2024 Reduced 2.77%
CPRX Catalyst Pharmaceuticals, Inc.	$2.32B	$292,000 0.01% of portfolio	14,730	Q3 2024 New
BMRN Biomarin Pharmaceutical Inc	$11.8B	$239,000 0.01% of portfolio	3,402	Q3 2024 New
IDYA Ideaya Biosciences, Inc.	$1.17B	$212,000 0.01% of portfolio	6,708	Q3 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$217M	$207,000 0.01% of portfolio	17,924	Q3 2024 New
HALO Halozyme Therapeutics, Inc.	$7.89B	$132,000 0.0% of portfolio	2,315	Q3 2024 Reduced 76.62%
ENOB Enochian Biosciences Inc	$244M	$77,000 0.0% of portfolio	16,954	Q3 2024 New
EDIT Editas Medicine, Inc.	$90M	$66,000 0.0% of portfolio	19,416	Q3 2024 New
DSGN Design Therapeutics, Inc.	$271M	$64,000 0.0% of portfolio	11,902	Q3 2024 New
ALDX Aldeyra Therapeutics, Inc.	$320M	$62,000 0.0% of portfolio	11,546	Q3 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$99.2M	$36,000 0.0% of portfolio	10,024	Q3 2024 New
LYEL Lyell Immunopharma, Inc.	$146M	$23,000 0.0% of portfolio	16,841	Q3 2024 New
INSM Insmed Inc	$10.4B	$12,000 0.0% of portfolio	177	Q3 2024 Reduced 26.25%

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.